Addex Therapeutics (ADXN) Net Income (2018 - 2026)
Addex Therapeutics (ADXN) posted Net Income of -$2185.9 billion for Q1 2026, down 51309368308.51% sequentially from -$4260.2 in Q4 2025, and down 33.43% YoY from -$3283.8 billion in Q1 2025.
Addex Therapeutics (ADXN) Net Income (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Net Income for 9 years, with the latest figure at -$2185.9 billion in Q1 2026.
- Quarterly Net Income fell 33.43% year-over-year to -$2185.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2185.9 billion (down 33.43% YoY) and the FY2025 annual result came in at $137911.1, down 98.99% from the prior year.
- Net Income eased to -$2185.9 billion in Q1 2026 per ADXN's latest filing, from -$4260.2 in the prior quarter.
- Over five years, Net Income peaked at $15.9 million in Q2 2024 and troughed at -$3536.9 billion in Q1 2024.
- A 5-year average of -$460.1 billion and a median of -$3.0 million in 2023 frame the typical range for Net Income.
- The widest YoY moves for Net Income: up 632.8% in 2024, down 135900948.17% in 2024.
- Over 5 years, Net Income stood at $6.6 million in 2022, then sank by 237.81% to -$9.1 million in 2023, then jumped by 99.8% to -$18155.9 in 2024, then soared by 76.54% to -$4260.2 in 2025, then tumbled by 51309368308.51% to -$2185.9 billion in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$2185.9 billion, -$4260.2, and $142225.5 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | -2,185.90 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,185.90 Bn |
| Dec 31, 2025 | -4,260.23 |
| Jun 30, 2025 | 142,225.45 |
| Mar 31, 2025 | -1,638.19 Bn |
| Dec 31, 2024 | -18,155.90 |
| Sep 30, 2024 | -2,770.10 |
| Jun 30, 2024 | 15.85 Mn |
| Mar 31, 2024 | -3,536.88 Bn |
| Dec 31, 2023 | -9.08 Mn |
| Sep 30, 2023 | -2.96 Mn |
| Jun 30, 2023 | -2.98 Mn |
| Mar 31, 2023 | -2.60 Mn |
| Dec 31, 2022 | 6.59 Mn |
| Sep 30, 2022 | -4.25 Mn |
| Jun 30, 2022 | -7.50 Mn |
| Mar 31, 2022 | -6.31 Mn |
| Dec 31, 2021 | -4.80 Mn |
| Sep 30, 2021 | -3.92 Mn |
| Jun 30, 2021 | -5.14 Mn |
| Mar 31, 2021 | -2.92 Mn |